| Date | Title | Description | Source |
| 08.03.2024 | Akero Therapeutics Announces Closing of Public Offering of C... | - | globenewsw... |
| 07.03.2024 | Akero Therapeutics Announces Publication of Phase 2b SYMMETR... | - | globenewsw... |
| 05.03.2024 | Akero Therapeutics Announces Pricing of Public Offering of C... | - | globenewsw... |
| 16.05.2023 | Akero Therapeutics Announces Pricing of $220.0 Million Under... | - | globenewsw... |
| 16.06.2022 | Akero Therapeutics Announces Two Financing Transactions with... | $25 Million Equity Investment by Pfizer at $9.90 Per Share | appletreep... |
| 16.06.2022 | Akero Therapeutics Announces Two Financing Transactions with... | $25 Million Equity Investment by Pfizer at $9.90 Per Share
Term Loan Facility from Hercules Providin... | globenewsw... |
| 16.06.2022 | Akero Therapeutics Announces Two Financing Transactions with... | $25 Million Equity Investment by Pfizer at $9.90 Per Share
Term Loan Facility from Hercules Providi... | appletreep... |
| 24.02.2021 | Akero Therapeutics Initiates Phase 2b HARMONY Study of Efrux... | | prnewswire... |
| 12.11.2020 | Akero Therapeutics Reports Third Quarter 2020 Financial Resu... | | prnewswire... |
| 16.10.2020 | Akero Therapeutics Receives European Medicines Agency Priori... | | prnewswire... |
| 31.03.2020 | Myovant grabs $40M upfront in regional deal for relug... | → Having just filed for the European approval of its uterine fibroids drug relugolix, Myov... | endpts.com... |
| 24.06.2019 | Akero Therapeutics Announces Closing of Initial Public Offer... | SAN FRANCISCO, June 24, 2019 -- (PRNewswire) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-... | appletreep... |
| 24.06.2019 | Akero Therapeutics Announces Closing of Initial Public Offer... | SAN FRANCISCO, June 24, 2019 -- (PRNewswire) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-... | appletreep... |
| 13.12.2018 | Akero Therapeutics Raises $70M in Financing | Akero Therapeutics, Inc., a San Francisco, CA-based biotechnology company developing transformationa... | finsmes.co... |
| 13.12.2018 |
Versant Backed Akero Therapeutics Gets $70M More
| Akero Therapeutics, a biotechnology startup backed by San Diego's Versant Ventures, which developing... | socaltech.... |
| 12.12.2018 | Akero Therapeutics Inks $70M in Series B |
SAN FRANCISCO, CA, Biotechnology company has closed $70 million in new Series B financing.
>&g... | vcnewsdail... |
| 26.06.2018 | Term Sheet — Tuesday, June 26 | VENTURE MEETS CRYPTO
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't ... | fortune.co... |
| 25.06.2018 | Akero picks up $65M to advance Amgen-licensed NASH drug | Akero Therapeutics raised $65 million in series A financing to advance its lead program, long-acting... | fiercebiot... |
| 25.06.2018 | Akero picks up $65M to advance Amgen-licensed NASH drug | Akero Therapeutics raised $65 million in series A financing to advance its lead program, long-acting... | fiercebiot... |
| 25.06.2018 | Akero Therapeutics Closes $65 Million Series A | Akero Therapeutics, Inc., a biotechnology company focused on transforming the treatment of non-alcoh... | citybizlis... |
| 25.06.2018 | Akero Therapeutics Closes $65M Series A |
CAMBRIDGE, MA, Biotechnology company focused on transforming the treatment of non-alcoholic steato... | vcnewsdail... |
| 25.06.2018 | Akero Therapeutics Closes $65M Series A Financing | Akero Therapeutics, Inc., a Cambridge, MA-based biotechnology company focused on treatment of non-al... | finsmes.co... |
